Ultimately, it was demonstrated that low T cell count, specifically Tc, as well as overactivation of T cells indicated by CD38 overexpression on CD4+/CD8+ T cells, had a prognostic role to predict mortality and severity among patients with COVID-19 and that these factors can shed light on the expected patients’ outcomes. The gene discussed is CD4; the disease is COVID-19.